Related Experiment Video
Updated: Aug 16, 2026
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Neonatal cerebral hypoxia-ischemia: involvement of FAK-dependent pathway
Teresa Zalewska1, Dorota Makarewicz, Bernardetta Janik
1NeuroRepair Department, Medical Research Institute, Polish Academy of Sciences, 5 Pawinskiego Str., 02-106 Warsaw, Poland. terezal@cmdik.pan.pl
Abstract:
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase thought to play a major role in transducing extracellular matrix (ECM)-derived survival signals into cells. Thus, modulation of FAK activity may affect the linkage between ECM and signaling cascade to which it is connected and may participate in a variety of pathological settings. In the present study, we investigated the effect of neonatal cerebral hypoxia-ischemia (HI) on levels and tyrosine phosphorylation of focal adhesion kinase and the interaction of this enzyme with Src protein tyrosine kinase and adapter protein p130Cas, involved in FAK-mediated signaling pathway. The total amount of focal adhesion kinase as well as its phosphorylated form declined substantially to about 50% of the control between 24 and 48 h after the insult. Concomitantly a decreased association of FAK with its investigated molecular partners, Src kinase and p130Cas protein has been observed. This early response to brain hypoxia-ischemia was attenuated during prolonged recovery with almost complete return to control values at 7 days. These data are indicative of an involvement of FAK-dependent signaling pathway in the evolution of HI-induced neuronal degeneration.
Insights
Neonatal brain hypoxia-ischemia (HI) significantly reduces focal adhesion kinase (FAK) levels and its interaction with key signaling partners. This early FAK pathway disruption may contribute to neuronal degeneration after HI injury.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Focal adhesion kinase (FAK) is a critical non-receptor tyrosine kinase.
- FAK mediates extracellular matrix (ECM)-derived survival signals, linking ECM to intracellular signaling cascades.
- FAK dysregulation is implicated in various pathological conditions.
Purpose of the Study:
- To investigate the impact of neonatal cerebral hypoxia-ischemia (HI) on FAK.
- To examine FAK's interaction with Src kinase and p130Cas following HI.
- To understand the role of the FAK signaling pathway in HI-induced neuronal degeneration.
Main Methods:
- Analysis of FAK total levels and tyrosine phosphorylation after neonatal cerebral HI.
- Assessment of FAK's association with Src kinase and p130Cas.
- Time-course study evaluating changes at 24, 48 hours, and 7 days post-insult.
Main Results:
- A substantial decrease (approx. 50%) in both total and phosphorylated FAK levels was observed 24-48 hours after HI.
- Concomitantly, FAK's association with Src kinase and p130Cas was significantly reduced.
- These early changes were transient, with near-complete recovery by 7 days post-HI.
Conclusions:
- The FAK-dependent signaling pathway is acutely affected by neonatal cerebral hypoxia-ischemia.
- Early alterations in FAK levels and its molecular interactions suggest a role in HI-induced neuronal damage.
- FAK signaling may be a key mediator in the evolution of neuronal degeneration following perinatal brain injury.
